Complementarity of binding motifs is a general property of HLA-A and HLA-B molecules and does not seem to effect HLA haplotype composition

Frontiers in Immunology

Volumn 4, Issue NOV, 2013, Pages

  Rao, Xiangyu ^a   De Boer, Rob J ^a   van Baarle, Debbie ^b   Maiers, Martin ^c   Kesmir, Can ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL MARROW DONOR PROGRAM   (United States)

Author keywords

Bioinformatics; Computational biology; Genetic; Haplotypes; HLA antigens; Peptide binding; Selection

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ARTICLE; BINDING AFFINITY; CHROMOSOME NUMBER; DISEASE ASSOCIATION; GENE FREQUENCY; HAPLOTYPE; PROTEIN BINDING; SAMPLE SIZE;

EID: 84890359224     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00374     Document Type: Article

References (31)

1. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 283:1748-52. doi: 10.1126/science.283.5408.1748
2. Apanius V, Penn D, Slev PR, Ruff LR, Potts WK. The nature of selection on the major histocompatibility complex. Crit Rev Immunol (1997) 17:179-224. doi:10.1615/CritRevImmunol.v17.i2.40
3. Boehm T, Zufall F. MHC peptides and the sensory evaluation of genotype. Trends Neurosci (2006) 29:100-7. doi:10.1016/j.tins.2005.11.006
4. De Boer RJ, Borghans JAM, van Boven M, Kesmir C, Weissing FJ. Heterozygote advantage fails to explain the high degree of polymorphism of the MHC. Immunogenetics (2004) 55:725-31. doi:10.1007/s00251-003-0629-y
5. O'Sullivan D, Arrhenius T, Sidney J, Del Guercio MF, Albertson M, Wall M, et al. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J Immunol (1991) 1950(147):2663-9.
6. Axelsson-Robertson R, Weichold F, Sizemore D, Wulf M, Skeiky YA, Sadoff J, et al. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses. Immunology (2010) 129:496-505. doi:10.1111/j.1365-2567.2009.03201.x
7. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, et al. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur J Immunol (2007) 37:2419-33. doi:10.1002/eji.200737365
8. Nakagawa M, Kim KH, Gillam TM, Moscicki A-B. HLA class I binding promiscuity of the CD8 T-cell epitopes of human papillomavirus type 16 E6 protein. J Virol (2007) 81:1412-23. doi:10.1128/JVI.01768-06
9. Rao X, Hoof I, Costa AI, van Baarle D, Kesmir C. HLA class I allele promiscuity revisited. Immunogenetics (2011) 63:691-701. doi:10.1007/s00251-011-0552-6
10. Carrington M. Recombination within the human MHC. Immunol Rev (1999) 167:245-56. doi:10.1111/j.1600-065X.1999.tb01397.x
11. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol (1992) 1950(148):249-58.
12. Smith WP, Vu Q, Li SS, Hansen JA, Zhao LP, Geraghty DE. Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes. Genomics (2006) 87:561-71. doi:10.1016/j.ygeno.2005.11.020
13. Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, Li S, et al. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res (2008) 68:3532-9. doi:10.1158/0008-5472.CAN-07-6471
14. Albanidou-Farmaki E, Deligiannidis A, Markopoulos AK, Katsares V, Farmakis K, Parapanissiou E. HLA haplotypes in recurrent aphthous stomatitis: a mode of inheritance? Int J Immunogenet (2008) 35:427-32. doi:10.1111/j.1744-313X.2008.00801.x
15. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2009) 61:1-13. doi:10.1007/s00251-008-0341-z
16. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol (2007) 68:779-88. doi:10.1016/j.humimm.2007.04.005
17. Kollman C, Maiers M, Gragert L, Müller C, Setterholm M, Oudshoorn M, et al. Estimation of HLA-A,-B,-DRB1 haplotype frequencies using mixed resolution data from a National Registry with selective retyping of volunteers. Hum Immunol (2007) 68:950-8. doi:10.1016/j.humimm.2007.10.009
18. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet (1995) 56:799-810.
19. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol (1995) 12:921-7.
20. MacNamara A, Kadolsky U, Bangham CR, Asquith B. T-cell epitope prediction: rescaling can mask biological variation between MHC molecules. PLoS Comput Biol (2009) 5:e1000327. doi:10.1371/journal.pcbi.1000327
21. Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, Corbet S, et al. Sensitive quantitative predictions of peptide-MHC binding by a "Query by Committee" artificial neural network approach. Tissue Antigens (2003) 62:378-84. doi:10.1034/j.1399-0039.2003.00112.x
22. Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci (2003) 12:1007-17. doi:10.1110/ps.0239403
23. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med (2005) 56:303-20. doi:10.1146/annurev.med.56.082103.104540
24. Yan H, Papadopoulos N, Marra G, Perrera C, Jiricny J, Boland CR, et al. Conversion of diploidy to haploidy. Nature (2000) 403:723-4. doi:10.1038/35002251
25. Douglas JA, Boehnke M, Gillanders E, Trent JM, Gruber SB. Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies. Nat Genet (2001) 28:361-4. doi:10.1038/ng582
26. Niu T. Algorithms for inferring haplotypes. Genet Epidemiol (2004) 27:334-47. doi:10.1002/gepi.20024
27. Bettencourt BF, Santos MR, Fialho RN, Couto AR, Peixoto MJ, Pinheiro JP, et al. Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics (2008) 9:68. doi:10.1186/1471-2105-9-68
28. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Pereira NF, Petzl-Erler ML, Donadi EA. Evaluation of computational methods for the reconstruction of HLA haplotypes. Tissue Antigens (2010) 76:459-66. doi:10.1111/j.1399-0039.2010.01539.x
29. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens (2003) 61:403-7. doi:10.1034/j.1399-0039.2003.00062.x
30. Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and-B locus protein of known sequence. PLoS One (2007) 2:e796. doi:10.1371/journal.pone.0000796
31. Capittini C, Pasi A, Bergamaschi P, Tinelli C, De Silvestri A, Mercati MP, et al. HLA haplotypes and birth weight variation: is your future going to be light or heavy? Tissue Antigens (2009) 74:156-63. doi:10.1111/j.1399-0039.2009.01282.x